CliffBio
small molecule

GILENYA

FINGOLIMOD HYDROCHLORIDE

Loss of exclusivityDecember 2027latest FDA-listed patent expiry
CompanyNovartis →See this company's full patent-cliff portfolio

Drug detail

Brand nameGILENYA
Active ingredientFINGOLIMOD HYDROCHLORIDE
StrengthEQ 0.5MG BASE
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2010
Marketing statusRX

Listed patents

PatentExpiresType
10543179December 2027use U-2719

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

GILENYA patent cliff — loss of exclusivity December 2027 | CliffBio